Yale Cardiovascular Medicine Grand Rounds "The Impact of Depression and Its Treatment on Cardiovascular Disease"

Bio

Bruce L. Rollman, MD, MPH, focuses on developing novel interventions to treat mood and anxiety disorders in primary care and cardiac settings. He has been principal investigator on six NIH-funded R01 clinical trials including the Online Treatment for Mood and Anxiety Disorders Trial that evaluated the impact of using a computerized cognitive behavioral therapy program and Internet support group to treat depression and anxiety in primary care; and the Hopeful Heart Trial that tested the effectiveness of a “blended" collaborative care model for treating both heart failure and depression. Dr. Rollman pioneered the use of electronic medical record system alerts to identify patients for enrollment into clinical trials at the time of the physician encounter and at-scale, including first-authored papers in the New England Journal of Medicine and the Journal of the American Medical Association, and has 4 U.S. patents. In 2015, he launched the Center for Behavioral Health and Smart Technology to mentor and support the careers of talented junior investigators.